|
2025
|
G/S
|
Educational services, namely, providing presentations in the field of oncology products and disea... |
|
|
G/S
|
Pharmaceutical preparations, applied subcutaneously, for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in neurological disorders including Alzheimer's |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheim... |
|
|
G/S
|
Pharmaceutical preparations for use in neuroscience |
|
|
Invention
|
Bicyclic ketone compounds and methods of use thereof.
Some embodiments of the invention provide ... |
|
|
Invention
|
Anchor points-based image segmentation for medical imaging.
A method that is implemented by one ... |
|
|
Invention
|
Cdk inhibitors.
The invention provides a compound represented by represented by the following st... |
|
|
Invention
|
Method to improve virus filtration capacity.
The present invention relates to the field of prote... |
|
|
Invention
|
Treatment of metastatic breast cancer.
The present invention concerns treatment of previously un... |
|
|
Invention
|
Machine learning enabled histological analysis.
A method may include applying a cell classificat... |
|
|
G/S
|
Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices |
|
|
Invention
|
Selection of diverse candidate peptides for peptide therapeutics.
A method for developing a ther... |
|
|
Invention
|
Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (ra).
The present i... |
|
|
Invention
|
Probabilistic identification of features for machine learning enabled cellular phenotyping.
A me... |
|
|
Invention
|
Compositions and methods of treating childhood onset idiopathic nephrotic syndrome.
The present ... |
|
|
Invention
|
Deep learning for non-compartmental analysis.
A method may include training a machine learning m... |
|
|
Invention
|
Methods and compositions comprising purified recombinant polypeptides.
Purified recombinant poly... |
|
|
Invention
|
Simultaneous imaging of nucleic acid and protein in a sample.
The present disclosure relates to ... |
|
|
Invention
|
Biomolecule fitness inference using machine learning for drug discovery with directed evolution. ... |
|
|
Invention
|
T cell quantitative systems pharmacology model.
A method may include determining, by at least on... |
|
|
Invention
|
Modulating lactogenic activity in mammalian cells.
The present disclosure relates to methods, ce... |
|
|
Invention
|
Molecule design with multi-objective optimization of partially ordered, mixed-variable molecular ... |
|
|
Invention
|
Optimizing polypeptide sialic acid content.
We provide a method of optimizing sialic acid conten... |
|
|
Invention
|
Methods for treatment of cd20-positive proliferative disorder with mosunetuzumab and polatuzumab ... |
|
|
Invention
|
Machine learning enabled prediction of molecular structures and properties.
A method may include... |
|
|
Invention
|
Techniques for determining dopaminergic neural cell loss using machine learning.
Described herei... |
|
|
Invention
|
Spacetime attention for clinical outcome prediction.
A disease prognosis model to may be trained... |
|
|
Invention
|
Cross-modality pixel alignment and cell-to-cell registration across various imaging modalities.
... |
|
|
Invention
|
Deep learning enabled segmentation of medical images with missing modalities. A first training sa... |
|
|
G/S
|
Software products for healthcare, monitoring, screening, assessment, diagnosis, and intervention,... |
|
|
Invention
|
Therapeutic and diagnostic methods for bladder cancer.
The invention provides methods and compos... |
|
|
Invention
|
Use of atr inhibitors in combination with pi3k alpha inhibitors. PIK3CAPIK3CAPIK3CA, by contactin... |
|
|
Invention
|
Methods for treatment of pancreatic cancer with anti-pd-l1 ab, anti-tigit ab, gemcitabine and nab... |
|
|
Invention
|
Data-independent acquisition (dia) for mass spectrometric analysis of mhc peptides. e.g.e.g., a p... |
|
|
Invention
|
Apparatus for and method in direct drug infusion using a label as a hanger.
An apparatus and met... |
|
|
Invention
|
Processes for making 1h-pyrazolo [3, 4-b] pyrazine compounds. Hbb]pyrazine compound of formula (I... |
|
|
Invention
|
Rna ligase variants. The present invention provides RNA ligase variants and its use in ligation r... |
|
|
Invention
|
Anti-c-c motif chemokine receptor 8 (ccr8) antibodies and methods of use.
The present disclosure... |
|
|
Invention
|
Methods and materials for measuring complement activation. e.g.e.g., in clinical samples, such as... |
|
|
Invention
|
Guab inhibitor compounds and uses thereof. e.g.e.g.e.g., tuberculosis, leprosy, nontuberculous my... |
|
|
Invention
|
Dosing for treatment with anti-fcrh5/anti-cd3 bispecific antibodies.
The invention provides meth... |
|
|
Invention
|
Method of treating hemophilia a. The present invention relates to methods of increasing hemoglobi... |
|
|
Invention
|
Methods of treating urothelial carcinoma with a pd-1 axis binding antagonist and an rna vaccine. ... |
|
|
Invention
|
Targeted protein degradation using bacterial e3 ligase. The present disclosure relates to a novel... |
|
2024
|
Invention
|
Anti-polyubiquitin antibodies.
The invention provides anti-polyubiquitin antibodies and methods ... |
|
|
G/S
|
Pharmaceutical preparations for use in immunology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology, neurology and immunology |
|
|
G/S
|
Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical... |
|
|
Invention
|
Combinatorial indexing for single-cell nucleic acid sequencing.
The present disclosure provides ... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological diseases |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of neurological conditions including Alzheimer. |
|
|
Invention
|
Therapeutic and diagnostic methods for cancer.
The present invention provides therapeutic, diagn... |
|
|
Invention
|
Compositions and methods of use.
The invention relates to compositions (e.g., pharmaceutical com... |
|
|
Invention
|
Prevention of disulfide bond reduction during recombinant production of polypeptides.
The invent... |
|
|
Invention
|
Lactams as cbl-b inhibitors.
Various lactam compound that binds Cbl-B, many of which are selecti... |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology |
|
|
G/S
|
Pharmaceutical preparations for use in ophthalmology. |
|
|
Invention
|
Biomarkers for predicting sensitivity to cancer treatments.
Provided herein are biomarkers, and ... |
|
|
G/S
|
Electronic data collection for business purposes in the medical field Downloadable and recorded c... |
|
|
G/S
|
Education, namely providing training in the field of oncology Medical services, namely, providing... |
|
|
G/S
|
Ophthalmological apparatus and instruments for ophthalmological surgery Education, namely providi... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology and hematology |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of neurological and neurodegenerativ... |
|
|
G/S
|
Pharmaceutical ophthalmic preparations |
|
2023
|
Invention
|
Display screen of a mobile terminal with graphical user interface |
|
|
Invention
|
Solid form of 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-met... |
|
|
Invention
|
Determining a patient’s response to a treatment in multiple myeloma.
The present disclosure rela... |
